IDT.AX

Healthcare Drug Manufacturers - Specialty & Generic

IDT Australia Limited

A$0.04

-0.00 -2.44% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 6, 2026, live at 3:11 PM ET	0.04

Key Stats

Market Cap

17.14M

Avg Volume

173,436

EPS

-A$0.01

52W High

A$0.07

52W Low

A$0.03

Div. Yield

0.0%

Valuation

Forward P/E

4.00

P/B Ratio

0.89

P/S Ratio

0.84

EV/EBITDA

-35.79

EV/Revenue

1.26

PEG Ratio

2.75

Margins

Gross Margin 59.9%

Operating Margin (7.0%)

Net Margin (13.3%)

EBITDA Margin (3.5%)

Growth & Returns

Revenue Growth (YoY)

14.8%

Return on Equity

(13.3%)

Return on Assets

(2.8%)

Liquidity & Leverage

Current Ratio

2.33

Quick Ratio

1.58

Debt / Equity

0.57

Total Cash

2.62M

Total Debt

10.82M

About

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies; psychedelics and medicinal cannabis; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

idtaus.com.au